Business Context and Reporting Period
This Form 8-K Current Report, dated October 10, 2025, covers corporate governance changes for Nature's Sunshine Products, Inc. (NATR). The filing details the departure of the former President and CEO, Terrence O. Moorehead, and the appointment of Kenneth Romanzi as the new Chief Executive Officer and Board member, effective October 29, 2025.
Key Financial Metrics
This filing does not contain standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and separation terms.
- New CEO Base Salary: $850,000 annually.
- New CEO Equity Grant (Time-based): Restricted Stock Units (RSUs) with a fair value of $1,500,000, vesting over three years.
- New CEO Equity Grant (Performance-based): Performance-contingent RSUs with a fair value of $1,500,000.
- Outgoing CEO Severance: 18 months of estimated base salary plus a pro-rated 2025 bonus.
Material Changes
The primary material change is the leadership transition at the executive level:
- Departure: Terrence O. Moorehead is resigning as President, CEO, and Board member effective October 29, 2025, following a notice given in May 2025.
- Appointment: Kenneth Romanzi, age 65, is appointed as CEO and Board member. He brings over 40 years of experience in consumer-packaged goods (CPG), including prior roles as CEO of B&G Foods, Inc., and leadership positions at Nabisco, Hasbro, and Ocean Spray.
Outlook, Risks, and Contingencies
Management Commentary: The Board selected Mr. Romanzi for his proven track record in leading transformations and driving growth within the CPG industry. His background includes experience with private equity firms Ronin Equity Partners and Astara Capital Partners.
Compensation Contingencies: Mr. Romanzi's employment agreement includes severance protections if terminated without cause or for "Good Reason," or within 18 months of a Change in Control. Mr. Moorehead's separation agreement includes retention of time-based and performance-contingent RSUs as if he remained employed during the 18-month severance period.
Risks: The filing does not explicitly list new operational risks, though executive transitions inherently carry execution risk during the handover period.
Investor Verification Checklist
- Verify the specific performance targets for Mr. Romanzi's $1.5 million performance-contingent RSU award, as these are set forth in a separate agreement.
- Review the full text of the Separation Agreement (Exhibit 10.2) to confirm the exact calculation of Mr. Moorehead's pro-rated bonus and the definition of "Good Reason."
- Monitor the press release (Exhibit 99.1) for any additional strategic commentary regarding the company's future direction under new leadership.
- Confirm the vesting schedule details for the time-based RSUs granted to Mr. Romanzi to assess future dilution impact.